Spain Market Access Director – Oncology Hta & P&R

Genmab A/S; Madrid; Sur place; EUR 60 000 - 90 000; Plein temps

Résumé du poste

Teva is seeking a Market Access Manager for Generics & Biosimilars in Spain to define and execute value, pricing and access strategies across the Spanish healthcare system. You will translate clinical value into payer-relevant evidence, supporting biosimilar adoption and sustainable competition.

You will work with national, regional and hospital decision-makers to optimise pricing, reimbursement and procurement, contributing to lifecycle management and access plans that accelerate market uptake.

Responsabilités

• Define and implement national value and access strategies for generics and biosimilars, with a specific focus on biosimilar adoption.
• Position biosimilars as high-quality, cost-effective and sustainability-enabling alternatives within the Spanish National Health System.
• Support lifecycle management strategies for off-patent products and biosimilars.
• Develop differentiated value documents to strengthen the positioning of generics and biosimilars within Brand Plans and Access Plans, ensuring the early integration of payer-relevant evidence and insights for healthcare decision-makers.

Description du poste

Market Access Manager - Generics and Biosimilars

We Are Teva We're Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it's innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we're dedicated to addressing patients' needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.

Our Team, Your Impact The Market Access Manager in Generics & Biosimilars (Spain) is responsible for defining and executing value, pricing and access strategies for Teva's portfolio of generics and biosimilars in the Spanish healthcare system, with a strong strategic focus on biosimilars.

In line with Teva's leadership position in generics and biosimilars and its commitment to healthcare system sustainability, this role ensures that the clinical value, economic impact and system benefits of biosimilars are clearly understood and recognized by national, regional and hospital‑level decision‑makers.

The position plays a critical role in supporting market uptake, tender success and sustainable competition, translating the value of biosimilars into practical access solutions aligned with Spain's pricing, reimbursement and procurement frameworks.

• Define and implement national value and access strategies for generics and biosimilars, with a specific focus on biosimilar adoption.
• Position biosimilars as high‑quality, cost‑effective and sustainability‑enabling alternatives within the Spanish National Health System.
• Support lifecycle management strategies for off‑patent products and biosimilars.
• Develop differentiated value documents to strengthen the positioning of generics and biosimilars within Brand Plans and Access Plans, ensuring the early integration of payer‑relevant evidence and insights for healthcare decision‑makers.
• Suport in Pricing, Contracting &